Prosthesis (i.e. – artificial body members) – parts thereof – or ai – Heart valve – Having rigid or semirigid pivoting occluder
Patent
1997-01-27
1998-12-01
Clarke, Robert A.
Prosthesis (i.e., artificial body members), parts thereof, or ai
Heart valve
Having rigid or semirigid pivoting occluder
A61F 224
Patent
active
058431829
ABSTRACT:
This disclosure includes a method for generating a functional hybrid bioprosthesis. Tissue formed naturally of interstitial collagens is treated to kill native cells and remove potentially immunologically active soluble molecules. Then it may be treated sequentially with extracellular matrix adhesion factor, extracellular matrix glycosaminoglycan, and growth factor appropriate to the cell type required to function within the matrix, and incubating the transplant tissue matrix with cells that are either allogeneic or autologous for the recipient thereby imparting to the matrix the characteristics of the cell type and tissue selected. Tissues with a variety of functional bioactivities can thus be formed in vitro prior to graft transplantation or implantation which will exhibit reduced or no stimulation of an immunological response in the recipient.
REFERENCES:
patent: 3966401 (1976-06-01), Hancock et al.
patent: 4083066 (1978-04-01), Schmitz et al.
patent: 4240794 (1980-12-01), Holman et al.
patent: 4323358 (1982-04-01), Lentz et al.
patent: 4378224 (1983-03-01), Nimni et al.
patent: 4383832 (1983-05-01), Fraefel et al.
patent: 4402697 (1983-09-01), Pollock et al.
patent: 4405327 (1983-09-01), Pollock
patent: 4407787 (1983-10-01), Stemberger
patent: 4485096 (1984-11-01), Bell
patent: 4539716 (1985-09-01), Bell
patent: 4546500 (1985-10-01), Bell
patent: 4553974 (1985-11-01), Dewanjee
patent: 4559298 (1985-12-01), Fahy
patent: 4567847 (1986-02-01), Linner
patent: 4609551 (1986-09-01), Caplan
patent: 4642120 (1987-02-01), Nevo et al.
patent: 4647283 (1987-03-01), Carpentier et al.
patent: 4648881 (1987-03-01), Carpentier et al.
patent: 4688387 (1987-08-01), Conaway
patent: 4707998 (1987-11-01), Linner et al.
patent: 4776853 (1988-10-01), Klement et al.
patent: 4785079 (1988-11-01), Gospodarowicz
patent: 4798611 (1989-01-01), Freeman, Jr.
patent: 4799361 (1989-01-01), Linner
patent: 4801299 (1989-01-01), Brendel et al.
patent: 4828563 (1989-05-01), Muller-Lierheim
patent: 4835102 (1989-05-01), Bell et al.
patent: 4838888 (1989-06-01), Nashef
patent: 4865871 (1989-09-01), Livesey et al.
patent: 4870160 (1989-09-01), Charonis et al.
patent: 4878913 (1989-11-01), Aebischer et al.
patent: 4890457 (1990-01-01), McNally et al.
patent: 4902782 (1990-02-01), Gospodarowicz
patent: 4911710 (1990-03-01), Milthorpe et al.
patent: 4950483 (1990-08-01), Ksander et al.
patent: 4960424 (1990-10-01), Grooters
patent: 4964280 (1990-10-01), Piunno et al.
patent: 4973493 (1990-11-01), Guire
patent: 5002566 (1991-03-01), Carpentier et al.
patent: 5145770 (1992-09-01), Tubo et al.
patent: 5192312 (1993-03-01), Orton
patent: 5197985 (1993-03-01), Caplan et al.
patent: 5215541 (1993-06-01), Nashef et al.
patent: 5294551 (1994-03-01), Furcht et al.
patent: 5336616 (1994-08-01), Livesey et al.
patent: 5512474 (1996-04-01), Clapper et al.
Benjamin Lewin, "Gene Expression", vol. 2 Eucaryotic Chromosomes, pp. 273-280.
Watson, et al., "Transferring Genes into Mammalian Cells", Recombinant DNA Second Edition, Scientific American Books, pp. 213-234.
Markmann, et al., "Indefinite Survival of MHC Class 1-Deficient Murine Pancreatic Islet Allografts", vol. 54 Transplantation Rapid Communications, pp. 1085-1089, Dec. 1992.
Osorio, et al., "Major Histocompatibility Complex class 1 Deficiencty Prolongs Islet Allograft Survival", Diabetes, vol. 42, Oct. 1993, pp. 1520-1527.
Kathryn J. Wood, "The induction of tolerance to alloantigens using MHC class 1 molecules", Current Biology Ltd. Univ. of Oxford, John Radcliffe Hospital, vol. 5, No. 5, pp. 759-762, 1993.
Burgert, et al., "An Adenovirus Type 2 Glycoprotein Blocks Cell Surface Expression of Human Histocompatibility Class 1 Antigens", Cell vol. 41, pp. 987-997, Jul. 1985.
Wold, et al., "Region E3 of Adenovirus: A Cassette of Genes Involved in Host Immunosurveillance and Virus-Cell Interactions", Virology vol. 184, No. 1, Sep. 1991.
Watson, et al., "Molecules of Immune Recognition", Recombinant DNA Second Edition, Scientific American Books, pp. 293-312.
Cytokine Research Products 1993, "Genzyme" Fibroblast Growth Factor Overview, pp. 81-83.
O'Brien, et al. A Comparison of Aortic Valve Replacement with Viable Cryopreserved and Fresh Allograft Valves, with a Note on Chromosomal Studies. J. Thoracic & Cardiovascular Surg. 94:812-823 (1987).
Slavkin, et al., Concepts of Epithelial-Mesenchymal Interactions During Development: Tooth and Lung Organogenesis. J. Cellular Bioch. 26:117-125 (1984).
Manu-Tawiah and Martin, Peat Extract as a Carbon Source for the Growth of Pleurotus ostreatus Mycelium. J. Sci. Food Agric. 47:243-247 (1989).
Nichols, et al., Cytogenetic Evaluation of Human Endothelial Cell Cultures. C. Cellular Phys. 132:453-462 (1987).
Nanchahal, et al., Cultured Composite Skin Grafts: Biological Skin Equivalents Permitting Massive Expansion. The Lanceyt 2 (1989) 22:191-193 (Jul. 22, 1989).
Shiogama, et al., An Improved Cryopreservation Procedure for Human Fetal Pancreas Tissues. Biological Abstracts, vol. 85, Abstract No. 46563 (1988).
Shingh, et al., Binding of Tumor-Derived Angiogenic Factor to High Affinity Receptor on Endothelial Cells. J. Cell Biology 103:299a, Abstract No. 1107 (1986).
Bell, et al., Living Tissue Formed in vitro and Accepted as Skin-Equivalent Tissue of Full Thickness. Science 211:1052-1054 (1981).
Weinberg and Bell, A Blood Vessel Model Constructed from Collegen and Cultured Vascular Cells. Science 231:397-400 (1986).
Kent, et al., Species Variation and the Success of Endothelial Seeding. J. Vascular Surg. 9:271-276 (1989).
Hoch, et al., In Vitro Endothelialization of an Aldehyde-Stablized Native Vessel. J. Surg. Res. 44:545-554 (1988).
Noyes, Culture of Human Fetal Liver. Proc. Soc. Exp. Biol. Med. 144:245-248 91973).
Leapman, et al., Transplantastion of Fetal Intestine: Survival and Function in a Subcutaneous Location in Adult animals. Ann. Surg. 179:109-114 (1974).
Brockbank, Repopulation of Xenograft Heart Valves with Fibroblasts. Small Business Innovation Research Grant Application No. PHS 90-2 (submitted Aug. 15, 1990).
Ninnemann, et al., Clinical Skin Banking: A Simplified System for Processing Storage, and Retrieval of Human Allografts. Third Denver Postgraduate Institute in Emergency Medicine, Denver General Hospital, Denver, Colorado, 723-725, (held Oct. 23-28, 1978).
Abbott, et al., Absence of Antigenicity in Freeze-Dried Skin Allografts. Cryobiology, vol. 6, No. 5, 416-418 (1970).
Athreya, et al., Differential Susceptibility of Epithelial Cells and Fibroblasts of Human Skin to Freeze Injury. Cryobiology, vol. 5, No. 4, 262-269 (1968).
Barlyn, et al., Frozen Skin Autografts Protected by Dimethyl Sulfoxide. Surgical Forum on Plastic Surgery, vol. XV, 475-477 (Oct. 1964).
Berggren, et al., Clinical Use of Viable Frozen Human Skin. JAMA vol. 194, No. 2, 129-131 (Oct. 1965).
Bondoc, et al., Clinical Experience with Viable Frozen Human Skin and a Frozen Skin Bank. Presented at Annual Meeting of American Surgical Association, Boca Raton, Florida (Mar. 24-26, 1971).
Brown, et al., Laboratory Investigations of Skin Viability Following Preservation by Various Methods. Surgical forum on Plastic Surgery, vol. VI, 577-581 (Nov. 1955).
Hodgson, Clague P., The Vector Void in Gene Therapy. Bio/Technology. vol. 13, 222-225 (Mar. 1995).
LaTerra et al., Functions For Fibronectin, Hyaluronate, and Heparan Proteoglycans in Substatum Adhesion of Fibroblasts, Extracellular. Matrix, 197-207, (1982).
Mulligan, The Basic Science of Gene Therapy. Science. vol. 260, 926-932, (May 1993).
Watson et al., Recombinant DNA. 2d ed. W.H. Freman & Company. (NY 1992).
Chambler, et al., The Use of Etox Lyophilised Skin in Burns. Journal Plastic Surgery 22(3) 210-215 (Jul. 1969).
Chalmers, Transplantation Immunity in Bone Homografting. Journal of Bone and Joint Surgery, vol. 41B, No. 1, 160-179 (Feb. 1959).
Cinamon, et al., A Simplified Testing System to Evaluate Performance After Transplantation of Human Skin Preserved in Glycerol or in Liquid Nitrogen. Journal of Burn Care & Rehabilitation, 435-439, (Jul./Aug. 1993).
Cochrane, et al., The Low Temperature Storage of S
Clarke Robert A.
Cryolife, Inc.
LandOfFree
Treated tissue for implantation and methods of preparation does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Treated tissue for implantation and methods of preparation, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Treated tissue for implantation and methods of preparation will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-2392118